SCHEMBL2805224

SCHEMBL2805224

N#Cc1c(NC(=O)OC(Cl)Cc2ccccc2)ncc2c1-c1ccccc1C(c1ccc(Cl)c(Cl)c1)C2

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 12/20 0.33
SLC6A2 P23975 11/20 0.33
SLC6A3 Q01959 11/20 0.33
FPR2 P25090 1/20 0.31
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
MAPK1 P28482 1/20 0.30
KCNH2 Q12809 3/20 0.30
GLP1R P43220 2/20 0.30
CYP2D6 P10635 3/20 0.30
CYP2C19 P33261 3/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803315 0.93 SLC6A4 (0.34) SLC6A4SLC6A2SLC6A3MAPTHTT
SCHEMBL2803267 0.91 SLC6A4 (0.33) SLC6A4SLC6A2SLC6A3FPR2MAPK1
SCHEMBL2802815 0.88 SLC6A2 (0.34) SLC6A4SLC6A2SLC6A3KCNH2CYP2D6
SCHEMBL2805897 0.87 FFAR1 (0.34) SLC6A4SLC6A2SLC6A3KCNH2CYP2D6
SCHEMBL17043983 0.85 SLC6A2 (0.35) SLC6A4SLC6A2SLC6A3KCNH2CYP2D6
SCHEMBL2802828 0.84 ALDH1A1 (0.34) SLC6A4SLC6A2SLC6A3LMNAMAPT
SCHEMBL2804693 0.83 ALDH1A1 (0.36) SLC6A4SLC6A2SLC6A3LMNAKCNH2
SCHEMBL2808980 0.83 SLC6A2 (0.34) SLC6A4SLC6A2SLC6A3KCNH2CYP2D6
SCHEMBL2805043 0.83 CHRM3 (0.37) SLC6A4SLC6A2SLC6A3KCNH2CYP2D6
SCHEMBL2805434 0.83 TDO2 (0.33) SLC6A4SLC6A2SLC6A3LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 SLC6A4 564/4885SLC6A2 233/4885SLC6A3 707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.